DRONEDARONE HYDROCHLORIDE
| Brand name | MULTAQ |
|---|---|
| Active ingredient | DRONEDARONE HYDROCHLORIDE |
| Strength | EQ 400MG BASE |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | July 2009 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 8602215 | June 2031 | use U-1473 |
| 8410167 | April 2029 | use U-1388 |
| 9107900 | April 2029 | use U-1726 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.